Young children with peanut allergy who received 12 months of treatment with a peanut patch had a significant difference in treatment response rate vs. those who received placebo, according to findings published in JAMA. However, the trial did not meet a prespecified criterion for a positive trial result.

“Several approaches to treating peanut allergy have been evaluated, including oral, sublingual, and epicutaneous immunotherapies,” David M. Fleischer, MD, of Children’s Hospital in Colorado and colleagues, wrote.